ICG Anastomotic Control in Digestive System Surgery

Launched by SHANDONG LINGLONG YINGCHENG HOSPITAL · Feb 14, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how a special dye called indocyanine green (ICG) can help doctors manage surgical connections in the digestive system, known as anastomoses, during surgeries like stomach or liver removals. The main goal is to see if using ICG can reduce the risk of problems like anastomotic leakage, which is when the connection between two parts of the intestine leaks. The study also looks at other factors that might affect recovery and surgical outcomes within 30 days after the surgery.

To be eligible to participate, patients should be between 18 and 90 years old and scheduled for elective surgery on their digestive system for either benign (non-cancerous) or malignant (cancerous) conditions. Participants need to have specific types of surgeries that involve creating a connection between two parts of the intestine. If you join this study, you will be monitored for 30 days after your surgery to see how well the procedure goes and if using ICG makes a difference in your recovery. This trial is important as it may help improve surgical care and outcomes for patients undergoing digestive surgeries.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • elective setting of surgery
• • digestive system surgery for benign or malignant pathology
• • 30 days of post-operative follow-up at least available from medical documentation
• • primary colo-colic or colo-rectal anastomosis with or without preventing ostomy
• • more than 18 years old, less than 90 years old
• Exclusion Criteria:
• • terminal colonic stoma without anastomosis creation after demolitive step
• • extended transverse right hemicolectomy
• • left hemicolectomy with high vascular ligation
• • associated bowel or another splanchnic resection (i.e. neoplastic infiltration)
• • previous colic surgery
• • synchronous neoplasm
• • not reporting in operating form details about vascular ligation
• • lack in reporting in medical records of primary outcomes
• • stage IV cancer
• • ASA IV
• • less than 18 years old, more then 90 years old
• • emergency setting